0001576280-21-000090.txt : 20210914
0001576280-21-000090.hdr.sgml : 20210914
20210914170732
ACCESSION NUMBER: 0001576280-21-000090
CONFORMED SUBMISSION TYPE: 4
PUBLIC DOCUMENT COUNT: 1
CONFORMED PERIOD OF REPORT: 20210910
FILED AS OF DATE: 20210914
DATE AS OF CHANGE: 20210914
REPORTING-OWNER:
OWNER DATA:
COMPANY CONFORMED NAME: MERESMAN STANLEY J
CENTRAL INDEX KEY: 0001283102
FILING VALUES:
FORM TYPE: 4
SEC ACT: 1934 Act
SEC FILE NUMBER: 001-38683
FILM NUMBER: 211253117
MAIL ADDRESS:
STREET 1: 2071 HUNTINGTON LANE
CITY: LOS ALTOS
STATE: CA
ZIP: 94024
ISSUER:
COMPANY DATA:
COMPANY CONFORMED NAME: Guardant Health, Inc.
CENTRAL INDEX KEY: 0001576280
STANDARD INDUSTRIAL CLASSIFICATION: SERVICES-MEDICAL LABORATORIES [8071]
IRS NUMBER: 454139254
STATE OF INCORPORATION: DE
FISCAL YEAR END: 1231
BUSINESS ADDRESS:
STREET 1: 505 PENOBSCOT DR.
CITY: REDWOOD CITY
STATE: CA
ZIP: 94063
BUSINESS PHONE: 855-698-8887
MAIL ADDRESS:
STREET 1: 505 PENOBSCOT DR.
CITY: REDWOOD CITY
STATE: CA
ZIP: 94063
4
1
wf-form4_163165363552010.xml
FORM 4
X0306
4
2021-09-10
0
0001576280
Guardant Health, Inc.
GH
0001283102
MERESMAN STANLEY J
505 PENOBSCOT DRIVE
REDWOOD CITY
CA
94063
1
0
0
0
COMMON STOCK
2021-09-10
4
M
0
4934
5.94
A
8993
D
COMMON STOCK
2021-09-10
4
S
0
3052
129.3101
D
5941
D
COMMON STOCK
2021-09-10
4
S
0
1082
130.1116
D
4859
D
COMMON STOCK
2021-09-10
4
S
0
800
131.12
D
4059
D
STOCK OPTION (RIGHT TO BUY)
5.94
2021-09-10
4
M
0
4934
0
D
2028-05-09
COMMON STOCK
4934.0
39473
D
These shares were sold under a pre-arranged sales plan pursuant to Rule 10b5-1 under the Securities Exchange Act of 1934, as amended.
The price reported in Column 4 is a weighted average price. The shares were sold in multiple transactions at prices ranging from $128.85 to $129.78, inclusive. The Reporting Person undertakes to provide to the Issuer, any security holder of the Issuer, or the staff of the Securities and Exchange Commission, upon request, full information regarding the number of shares sold at each separate price within the ranges set forth in this footnote.
The price reported in Column 4 is a weighted average price. The shares were sold in multiple transactions at prices ranging from $129.86 to $130.46, inclusive. The Reporting Person undertakes to provide to the Issuer, any security holder of the Issuer, or the staff of the Securities and Exchange Commission, upon request, full information regarding the number of shares sold at each separate price within the ranges set forth in this footnote.
The stock option vests and becomes exercisable in equal monthly installments over 48 months commencing on May 10, 2018.
/s/ John Saia, as attorney-in-fact for Stanley J Meresman
2021-09-14